Berger & Montague's attorneys are investigating
claims on behalf of those who took prescription drug Bravelle
between March 2014 and October 2015.
The attorneys at Berger & Montague are currently
investigating claims on behalf of patients throughout the country
who took Bravelle, a fertility drug that was recently recalled due
to lack of potency. In addition to money and time wasted on
ineffective treatments, patients who took Bravelle may have exposed
themselves to unnecessary health risks. If you or a loved one
has taken Bravelle between March 2014 and October 2015, call Berger
& Montague to speak with an attorney today, free of charge.
Implications of the Bravelle Recall
In October 2015, Ferring Pharmaceuticals pulled Bravelle
off the market after quality testing revealed that certain batches
distributed throughout the country "did not meet potency
specifications for their full 24-month shelf life." While it
is unclear whether the reduced therapeutic effect would cause
adverse health consequences in the short term, there is a potential
for unnecessary over-exposure, as all fertility drugs carry risks,
even at doses too low to cause pregnancy. Potential side
effects of Bravelle include ovarian hyper-stimulation syndrome,
ovarian torsion, birth defects, and blood clots.
In addition to compensation related to these risks of side
effects, patients who took Bravelle may be able to recover costs
associated with IVF procedures, as well as the cost of the
Do you have a Bravelle claim?
If you have taken Bravelle between March 2014 and October
2015, you may be able to collect compensation for costs associated
with failed treatments. If you or a loved one has taken
Bravelle, do not hesitate to contact Berger & Montague to speak
with an attorney, free of charge. Either call us at (215)
875-3015, or fill out the form on the right to have an attorney
A copy of the court's opinion can be accessed and
downloaded by clicking here (PDF).